Marsha Rosner: CBD (Cannabidiol), Antiviral Drugs, SARS-CoV-2 & Cancer Biology
About the Guest: Marsha Rosner, PhD is a cancer biologist and Professor of Cancer Research at the University of Chicago. Her lab focuses largely on understanding the biochemical signaling mechanisms that lead to the generation of tumor cells, as well as how and why cancer cells metastasize, which is when they travel from one part of the body to another. Her work on how cells sense and respond to stress has also led her lab to study cannabidiol (CBD) and its effects on inflammation and viral infection.
Episode Summary: Nick Jikomes spoke to Dr. Rosner mainly about a recent study she led about the antiviral effects of cannabidiol (CBD) against SARS-CoV-2, including: why a cancer lab was working with CBD to begin with; what the results of her study actually show in terms of CBD’s antiviral effects; whether other cannabinoids showed this effect. She also commented on some misconceptions that have been circulating regarding this work, and described some of the clinical trials her team is running to measure CBD’s potential as an anti-COVID drug.